Enkephalin, morphine, and naloxone in tardive dyskinesia

Niels Bjørndal, Daniel Casey, Jes Gerlach

Research output: Contribution to journalArticle

22 Scopus citations

Abstract

Eight psychiatric patients with tardive dyskinesia (TD) were treated with single doses of the synthetic met-enkephalin analogue FK 33-824 (1, 2, and 3 mg IM) morphine (10 mg SC) and naloxone, an opiate receptor antagonist (0.8 mg IM). The drug effects were assessed by blind evaluation of randomly sequenced videotapes made before and during treatment. FK 33-824 (1,2, and 3 mg IM) slightly reduced TD (P

Original languageEnglish (US)
Pages (from-to)133-136
Number of pages4
JournalPsychopharmacology
Volume69
Issue number2
DOIs
Publication statusPublished - Jul 1980

    Fingerprint

Keywords

  • Enkephalin
  • Morphine
  • Naloxone
  • Parkinsonism
  • Tardive dyskinesia

ASJC Scopus subject areas

  • Pharmacology

Cite this